Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Korf, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korf, B. R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review Article : Clinical Features and Pathobiology of Neurofibromatosis 1

Bruce R. Korf, MD, PhD

Harvard-Partners Center for Genetics and Genomics, Boston, MA

Neurofibromatosis 1 is a progressive multisystem disorder. The hallmark feature is the occurrence of nerve sheath tumors, neurofibromas. Other features include tumors such as optic gliomas and malignant peripheral nerve sheath tumors. There are also nontumor manifestations, such as skeletal dysplasia and learning disabilities. Since the NF1 gene was identified, much has been learned about the molecular genetics of the disorder; recently, this has led to insights about pathogenesis. Ultimately, it is hoped that this will be translated into specific means of treatment. This review describes the various clinical features of neurofibromatosis 1 and considers them in the context of the pathophysiology of the disorder. (J Child Neurol 2002; 17:573-577).

Journal of Child Neurology, Vol. 17, No. 8, 573-577 (2002)
DOI: 10.1177/088307380201700806
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
V. C. Williams, J. Lucas, M. A. Babcock, D. H. Gutmann, B. Korf, and B. L. Maria
Neurofibromatosis Type 1 Revisited
Pediatrics, January 1, 2009; 123(1): 124 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
V.-F. Mautner, F. A. Asuagbor, E. Dombi, C. Funsterer, L. Kluwe, R. Wenzel, B. C. Widemann, and J. M. Friedman
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Neuro-oncol, August 1, 2008; 10(4): 593 - 598.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
L. Margari, A. Presicci, P. Ventura, S. M. Bacca, G. Iliceto, N. Medicamento, M. Buttiglione, and T. Perniola
Clinical and Instrumental (Magnetic Resonance Imaging [MRI] and Multimodal Evoked Potentials) Follow-Up of Brain Lesions in Three Young Patients With Neurofibromatosis 1
J Child Neurol, December 1, 2006; 21(12): 1085 - 1090.
[Abstract] [PDF]